View More
In this interactive program, Raymond T. Chung, MD, reviews current challenges with HCV therapies, describes novel classes of anti-HCV agents and their anticipated benefits for patients, and walks through a series of cases designed to evaluate the question of treating now vs waiting for future HCV therapies.
Raymond T. Chung, MD
Physicians:
maximum of 1.0 AMA PRA Category 1 Credit™
Released: December 12, 2012
Expiration: December 11, 2013
In this downloadable slideset, Raymond T. Chung, MD, reviews challenges with current HCV therapies and emerging treatment strategies with novel HCV agents.
Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270
Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.